Study Description
This is a multicenter, single-arm, non-interventional study (NIS) with a central registration system and an all-case surveillance system. The observation period is 48 weeks after the start of treatment with Fabhalta. The observation period will be 48 weeks after the start of treatment with Fabhalta.
For patients in whom treatment with Fabhalta is discontinued within 48 weeks after the start of the treatment, adverse events occurring by the last day of the treatment + 30 days and concomitant drugs will be monitored and recorded in CRFs.
Eligibility Criteria
Inclusion Criteria:
All patients who received Fabhalta.
·
Exclusion Criteria:
Patients receiving Fabhalta for an unapproved indication under the Clinical Trials Act or GCP.
Novartis Investigative Site
Recruiting
Kurume-city,Fukuoka,830-8543,Japan
Novartis Investigative Site
Recruiting
Uruma,Okinawa,904-2293,Japan
Novartis Investigative Site
Recruiting
Habikino City,Osaka,583-0872,Japan
Novartis Investigative Site
Recruiting
Miyazaki,880-8510,Japan
Novartis Investigative Site
Recruiting
Kanazawa,Ishikawa,920 8641,Japan
Novartis Investigative Site
Recruiting
Itabashi-ku,Tokyo,173-8610,Japan
Novartis Investigative Site
Recruiting
Shinagawa ku,Tokyo,141 8625,Japan
Novartis Investigative Site
Recruiting
Fukushima city,Fukushima,960 1295,Japan
Novartis Investigative Site
Recruiting
Moriguchi,Osaka,570-8540,Japan
Novartis Investigative Site
Recruiting
Niigata,951 8520,Japan
Novartis Investigative Site
Recruiting
Osaka,542-0081,Japan
Novartis Investigative Site
Recruiting
Sakaide-city,Kagawa,762-8550,Japan
Novartis Investigative Site
Recruiting
Minato-ku,Tokyo,105-8471,Japan
Novartis Investigative Site
Recruiting
Okazaki,Aichi,444-8553,Japan
Novartis Investigative Site
Recruiting
Fukuyama,Hiroshima,720-0001,Japan
Novartis Investigative Site
Recruiting
Saga-city,Saga,849-8501,Japan
Novartis Investigative Site
Recruiting
Shizuoka,422-8527,Japan
Novartis Investigative Site
Recruiting
Handa,Aichi,475-0817,Japan
Novartis Investigative Site
Recruiting
Yokohama city,Kanagawa,232 0024,Japan
Novartis Investigative Site
Recruiting
Nerima,Tokyo,113-0033,Japan
Novartis Investigative Site
Recruiting
Toyota,Aichi,471-8513,Japan
Novartis Investigative Site
Recruiting
Hakodate,Hokkaido,041-0821,Japan
Novartis Investigative Site
Recruiting
Fukaya,Saitama,366-0052,Japan
Novartis Investigative Site
Recruiting
Toyama,930-0859,Japan
Novartis Investigative Site
Recruiting
Nagoya,Aichi,453-8511,Japan
Novartis Investigative Site
Recruiting
Osaki,Miyagi,989-6183,Japan
Novartis Investigative Site
Recruiting
Shinjuku Ku,Tokyo,160-0023,Japan
Novartis Investigative Site
Recruiting
Kobe,Hyogo,650-0047,Japan
Novartis Investigative Site
Recruiting
Sapporo,Hokkaido,003-0006,Japan
Novartis Investigative Site
Recruiting
Kawagoe,Saitama,350 8550,Japan
Novartis Investigative Site
Recruiting
Toyohashi,Aichi,441-8570,Japan
Novartis Investigative Site
Recruiting
Suwa,Nagano,392-8510,Japan
Novartis Investigative Site
Recruiting
Kanoya,Kagoshima,893-0024,Japan
Novartis Investigative Site
Recruiting
Kyoto,604-8845,Japan
Novartis Investigative Site
Recruiting
Tsukuba,Ibaraki,300-2622,Japan
Novartis Investigative Site
Recruiting
Hikone,Shiga,522-0057,Japan
Novartis Investigative Site
Recruiting
Matsuyama,Ehime,790-8524,Japan
Novartis Investigative Site
Recruiting
Beppu,Oita,874-0840,Japan
Novartis Investigative Site
Recruiting
Isehara,Kanagawa,259-1193,Japan
Novartis Investigative Site
Recruiting
Kyoto,606 8507,Japan
Novartis Investigative Site
Recruiting
Tsukuba,Ibaraki,305-8576,Japan
Novartis Investigative Site
Recruiting
Iwata,Shizuoka,438-8550,Japan
Worldwide Contacts
If the location of your choosing does not feature any contact detail, please reach out using the information below.